These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28895412)

  • 21. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
    Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
    Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of PLAC1 and Netrin-1 in liver metastasis of colorectal cancer and its predictive value.
    Wang Z; Deng L; Xu X; Zhao L
    BMC Gastroenterol; 2023 Aug; 23(1):275. PubMed ID: 37568074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
    Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
    BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
    Chen L; Qiu X; Wang X; He J
    Biochem Biophys Res Commun; 2017 May; 487(1):8-14. PubMed ID: 28302482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and significance of pigment epithelium-derived factor and vascular endothelial growth factor in colorectal adenoma and cancer.
    Yang Y; Wen W; Chen FL; Zhang YJ; Liu XC; Yang XY; Hu SS; Jiang Y; Yuan J
    World J Gastrointest Oncol; 2024 Mar; 16(3):670-686. PubMed ID: 38577437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
    Yuan D; Liu B; Liu K; Zhu G; Dai Z; Xie Y
    J Surg Oncol; 2013 Sep; 108(3):157-62. PubMed ID: 23813624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
    Jin M; Long ZW; Yang J; Lin X
    Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
    J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of vasohibin-1 in colorectal cancer tissue and its correlation with vascular endothelial growth factor A and microvessei density].
    Shi G; Hao J; Wang L; He B; Gan J; Wang H; Suo R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):272-6. PubMed ID: 25809333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
    Ru GQ; Zhao ZS; Tang QL; Xu WJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
    Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
    BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
    Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Kitadai Y; Yoshihara M; Chayama K; Shimamoto F
    Oncology; 2002; 62(2):157-66. PubMed ID: 11914602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
    Takahashi Y; Sawada G; Sato T; Kurashige J; Mima K; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Tanaka J; Kudo SE; Doki Y; Mori M; Mimori K
    Oncol Rep; 2013 Sep; 30(3):1488-96. PubMed ID: 23835740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
    Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
    Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.